Exact Mass: 594.3685

Exact Mass Matches: 594.3685

Found 75 metabolites which its exact mass value is equals to given mass value 594.3685, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

7,8-Dehydroastaxanthianthin

6-hydroxy-3-[(1E,3E,5E,7Z,9E,11E,13E,15Z)-18-(4-hydroxy-2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15-octaen-17-yn-1-yl]-2,4,4-trimethylcyclohex-2-en-1-one

C40H50O4 (594.3709)


7,8-Dehydroastaxanthianthin is found in crustaceans. 7,8-Dehydroastaxanthianthin is found in lobster eggs. Found in lobster eggs

   

Cholyltryptophan

2-[(1-Hydroxy-4-{5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0,.0,]heptadecan-14-yl}pentylidene)amino]-3-(1H-indol-3-yl)propanoate

C35H50N2O6 (594.3669)


Cholyltryptophan belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Cholyltryptophan consists of the bile acid cholic acid conjugated to the amino acid Tryptophan conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Cholyltryptophan, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Cholyltryptophan appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).

   

Capsicoside A1

2-(hydroxymethyl)-6-{5,7,9,13-tetramethyl-5-oxaspiro[oxane-2,6-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-15-oloxy}oxane-3,4,5-triol

C33H54O9 (594.3768)


Capsicoside a1 is a member of the class of compounds known as steroidal saponins. Steroidal saponins are saponins in which the aglycone moiety is a steroid. The steroidal aglycone is usually a spirostane, furostane, spirosolane, solanidane, or curcubitacin derivative. Capsicoside a1 is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Capsicoside a1 can be found in a number of food items such as red bell pepper, yellow bell pepper, pepper (c. annuum), and orange bell pepper, which makes capsicoside a1 a potential biomarker for the consumption of these food products.

   

Aldecalmycin

Aldecalmycin

C33H54O9 (594.3768)


   

Dioseptemloside B

Dioseptemloside B

C33H54O9 (594.3768)


   

(3S,3S,4R)-4-keto-4-Hydroxyalloxanthin

(3S,3S,4R)-7,7,8,8-Tetradehydro-3,3,4-trihydroxy-beta,beta-caroten-4-one

C40H50O4 (594.3709)


   

4-Keto-4-hydroxyalloxanthin

(3S,3S,4S)-7,7,8,8-Tetradehydro-3,3,4-trihydroxy-beta,beta-caroten-4-one

C40H50O4 (594.3709)


   

Furostane base -2H + O-Hex

Furostane base -2H + O-Hex

C33H54O9 (594.3768)


Annotation level-3

   

16beta-[(beta-D-glucopyranosyl)oxy]-3beta,7beta-dihydroxycholest-5-en-23-one|16??-[(??-D-Glucopyranosyl)-oxy]-3??,7??-dihydroxycholest-5-en-23-one

16beta-[(beta-D-glucopyranosyl)oxy]-3beta,7beta-dihydroxycholest-5-en-23-one|16??-[(??-D-Glucopyranosyl)-oxy]-3??,7??-dihydroxycholest-5-en-23-one

C33H54O9 (594.3768)


   

(25R)-6alpha-hydroxy-5alpha-spirostan-3beta-yl beta-D-glucopyranoside|chlorogenin 3beta-O-beta-D-glucopyranoside

(25R)-6alpha-hydroxy-5alpha-spirostan-3beta-yl beta-D-glucopyranoside|chlorogenin 3beta-O-beta-D-glucopyranoside

C33H54O9 (594.3768)


   

2,22-deoxyecdysone 25-O-beta-D-glucopyranoside

2,22-deoxyecdysone 25-O-beta-D-glucopyranoside

C33H54O9 (594.3768)


   

capsicoside A1

capsicoside A1

C33H54O9 (594.3768)


   

Polyphyllin A

Polyphyllin A

C33H54O9 (594.3768)


   

22-Epirhodeasapogenin-3-O-??-D-glucopyranoside

22-Epirhodeasapogenin-3-O-??-D-glucopyranoside

C33H54O9 (594.3768)


   

11-O-Beta-D-Galactopyranoside-(3beta,5beta,11alpha,25R)-Spirostane-3,11-diol

11-O-Beta-D-Galactopyranoside-(3beta,5beta,11alpha,25R)-Spirostane-3,11-diol

C33H54O9 (594.3768)


   

3beta,11alpha,16beta-trihydroxycholest-5,25(26)-dien-24-yl beta-D-glucopyranoside

3beta,11alpha,16beta-trihydroxycholest-5,25(26)-dien-24-yl beta-D-glucopyranoside

C33H54O9 (594.3768)


   

(25S)-spirostane-3beta,5beta-diol 5-beta-D-glucopyranoside|reinocarnoside B

(25S)-spirostane-3beta,5beta-diol 5-beta-D-glucopyranoside|reinocarnoside B

C33H54O9 (594.3768)


   

2,3-Didehydro-3,3-dihydroxy-beta,beta-carotene-4,4-doone-(S)-form|2,3-Didehydro-3,3-dihydroxy-beta,beta-carotene-4,4-doone-(??)-form

2,3-Didehydro-3,3-dihydroxy-beta,beta-carotene-4,4-doone-(S)-form|2,3-Didehydro-3,3-dihydroxy-beta,beta-carotene-4,4-doone-(??)-form

C40H50O4 (594.3709)


   

3-Oxo-3,4,4-trioxo-beta-carotin|semiastacin

3-Oxo-3,4,4-trioxo-beta-carotin|semiastacin

C40H50O4 (594.3709)


   

(25R)-3beta-hydroxy-5alpha-spirostan-1beta-yl beta-D-glucopyranoside

(25R)-3beta-hydroxy-5alpha-spirostan-1beta-yl beta-D-glucopyranoside

C33H54O9 (594.3768)


   

Tryptophan conjugated cholic acid

Tryptophan conjugated cholic acid

C35H50N2O6 (594.3669)


   

7,8-Didehydroastaxanthin

7,8-Didehydroastaxanthin

C40H50O4 (594.3709)


D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

   

Asterinic acid

6-hydroxy-3-[(3Z,5E,7E,9E,11Z,13E,15E,17E)-18-(4-hydroxy-2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl)-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-1-yn-1-yl]-2,4,4-trimethylcyclohex-2-en-1-one

C40H50O4 (594.3709)


   

6-O-(Glcb)-(25R)-5alpha-spirostan-3beta,6alpha-diol

(25R)-5alpha-spirostan-3beta,6alpha-diol 6-O-beta-D-glucopyranoside

C33H54O9 (594.3768)


   

Semi-astacene

3,3-Dihydroxy-2,3-didehydro-beta,beta-carotene-4,4-dione

C40H50O4 (594.3709)


   

4-Hydroxy-4-ketoalloxanthin

(3S,3S,4R)-3,3,4-Trihydroxy-7,8,7,8-tetrahydro-beta,beta-caroten-4-one

C40H50O4 (594.3709)


   

tris(2,2,6,6-tetramethyl-3,5-heptanedionato)scandium(iii)

tris(2,2,6,6-tetramethyl-3,5-heptanedionato)scandium(iii)

C33H57O6Sc (594.3714)


   

Furostane base-2H + O-Hex

Furostane base-2H + O-Hex

C33H54O9 (594.3768)


   

Cholyltryptophan

Cholyltryptophan

C35H50N2O6 (594.3669)


   

2-[[3-Hexadecanoyloxy-2-(5-oxopentanoyloxy)propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-Hexadecanoyloxy-2-(5-oxopentanoyloxy)propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C29H57NO9P+ (594.3771)


   

1-O-palmitoyl-2-O-(5-oxovaleryl)-sn-glycero-3-phosphocholine(1+)

1-O-palmitoyl-2-O-(5-oxovaleryl)-sn-glycero-3-phosphocholine(1+)

C29H57NO9P+ (594.3771)


A 1,2-diacyl-sn-glycero-3-phosphocholine having palmitoyl and 5-oxovaleryl groups at the 1- and 2-positions respectively.

   

1-Hexadecyl-2-glutaryl-sn-glycero-3-phosphocholine(1-)

1-Hexadecyl-2-glutaryl-sn-glycero-3-phosphocholine(1-)

C29H57NO9P- (594.3771)


   

Mgdg O-20:5_4:0

Mgdg O-20:5_4:0

C33H54O9 (594.3768)


   

Mgdg O-18:5_6:0

Mgdg O-18:5_6:0

C33H54O9 (594.3768)


   

Mgdg O-22:5_2:0

Mgdg O-22:5_2:0

C33H54O9 (594.3768)


   

7,8-Dehydroastaxanthianthin

7,8-Dehydroastaxanthianthin

C40H50O4 (594.3709)


   

MGDG O-24:5

MGDG O-24:5

C33H54O9 (594.3768)


   
   
   
   

Didehydro-astaxanthin

Didehydro-astaxanthin

C40H50O4 (594.3709)


   
   
   
   
   

ST 27:1;O3;GlcA

ST 27:1;O3;GlcA

C33H54O9 (594.3768)


   

ST 27:2;O4;Hex

ST 27:2;O4;Hex

C33H54O9 (594.3768)


   

4-keto-4'-hydroxyalloxanthin

4-keto-4'-hydroxyalloxanthin

C40H50O4 (594.3709)


   

2-(hydroxymethyl)-6-{5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-oloxy}oxane-3,4,5-triol

2-(hydroxymethyl)-6-{5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-oloxy}oxane-3,4,5-triol

C33H54O9 (594.3768)


   

2-(hydroxymethyl)-6-{5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-19'-oloxy}oxane-3,4,5-triol

2-(hydroxymethyl)-6-{5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-19'-oloxy}oxane-3,4,5-triol

C33H54O9 (594.3768)


   

(2r,3r,4s,5r,6r)-2-(hydroxymethyl)-6-[(1'r,2r,2's,4's,5r,7's,8'r,9's,12's,13's,15'r,16'r,18's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-15'-oloxy]oxane-3,4,5-triol

(2r,3r,4s,5r,6r)-2-(hydroxymethyl)-6-[(1'r,2r,2's,4's,5r,7's,8'r,9's,12's,13's,15'r,16'r,18's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-15'-oloxy]oxane-3,4,5-triol

C33H54O9 (594.3768)


   

22-epirhodeasapogenin-3-o-β-d-glucopyrano-side

NA

C33H54O9 (594.3768)


{"Ingredient_id": "HBIN003728","Ingredient_name": "22-epirhodeasapogenin-3-o-\u03b2-d-glucopyrano-side","Alias": "NA","Ingredient_formula": "C33H54O9","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7004","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

2-(4,7-dihydroxy-9a,11a-dimethyl-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl)-6-methylheptan-4-one

2-(4,7-dihydroxy-9a,11a-dimethyl-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl)-6-methylheptan-4-one

C33H54O9 (594.3768)


   

(2r,3r,4s,5s,6r)-2-[(2r)-4-[(1s,2s,4s,6r,7s,8r,9s,12s,13r,16s)-6,16-dihydroxy-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-6-yl]-2-methylbutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-[(2r)-4-[(1s,2s,4s,6r,7s,8r,9s,12s,13r,16s)-6,16-dihydroxy-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-6-yl]-2-methylbutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C33H54O9 (594.3768)


   

3-[(1r,2s,4ar,6s,8r,8as)-2-[(2s,3r,4s,5e)-4-hydroxy-3,5-dimethyl-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oct-5-en-1-yl]-1,3,6,8-tetramethyl-4a,5,6,7,8,8a-hexahydro-2h-naphthalen-1-yl]-3-oxopropanal

3-[(1r,2s,4ar,6s,8r,8as)-2-[(2s,3r,4s,5e)-4-hydroxy-3,5-dimethyl-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oct-5-en-1-yl]-1,3,6,8-tetramethyl-4a,5,6,7,8,8a-hexahydro-2h-naphthalen-1-yl]-3-oxopropanal

C33H54O9 (594.3768)


   

6-hydroxy-3-[(9e,11e,13e,15e)-18-(4-hydroxy-2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15-octaen-17-yn-1-yl]-2,4,4-trimethylcyclohex-2-en-1-one

6-hydroxy-3-[(9e,11e,13e,15e)-18-(4-hydroxy-2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15-octaen-17-yn-1-yl]-2,4,4-trimethylcyclohex-2-en-1-one

C40H50O4 (594.3709)


   

2-(4-{6,16-dihydroxy-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-6-yl}-2-methylbutoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

2-(4-{6,16-dihydroxy-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-6-yl}-2-methylbutoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C33H54O9 (594.3768)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1'r,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,16's,18's,19's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-19'-oloxy]oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1'r,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,16's,18's,19's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-19'-oloxy]oxane-3,4,5-triol

C33H54O9 (594.3768)


   

(2r,3r,4s,5s,6r)-2-{[(1s,2s,4s,6r,7s,8r,9s,12s,13r,16s)-6-hydroxy-6-[(3r)-4-hydroxy-3-methylbutyl]-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-16-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1s,2s,4s,6r,7s,8r,9s,12s,13r,16s)-6-hydroxy-6-[(3r)-4-hydroxy-3-methylbutyl]-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-16-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C33H54O9 (594.3768)


   

3-[(1s,2r,4ar,6s,8s,8ar)-2-[(2s,3s,4r,5e)-4-hydroxy-3,5-dimethyl-2-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oct-5-en-1-yl]-1,3,6,8-tetramethyl-4a,5,6,7,8,8a-hexahydro-2h-naphthalen-1-yl]-3-oxopropanal

3-[(1s,2r,4ar,6s,8s,8ar)-2-[(2s,3s,4r,5e)-4-hydroxy-3,5-dimethyl-2-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oct-5-en-1-yl]-1,3,6,8-tetramethyl-4a,5,6,7,8,8a-hexahydro-2h-naphthalen-1-yl]-3-oxopropanal

C33H54O9 (594.3768)


   

(6s)-6-hydroxy-3-[(3e,5e,7e,9e,11e,13e,15e,17e)-18-[(4s)-4-hydroxy-2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-1-yn-1-yl]-2,4,4-trimethylcyclohex-2-en-1-one

(6s)-6-hydroxy-3-[(3e,5e,7e,9e,11e,13e,15e,17e)-18-[(4s)-4-hydroxy-2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-1-yn-1-yl]-2,4,4-trimethylcyclohex-2-en-1-one

C40H50O4 (594.3709)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1'r,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,16's,18's,19's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-oloxy]oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1'r,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,16's,18's,19's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-oloxy]oxane-3,4,5-triol

C33H54O9 (594.3768)


   

2-(hydroxymethyl)-6-{5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-15'-oloxy}oxane-3,4,5-triol

2-(hydroxymethyl)-6-{5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-15'-oloxy}oxane-3,4,5-triol

C33H54O9 (594.3768)


   

nor-q.d.; ethinyl estradiol

nor-q.d.; ethinyl estradiol

C40H50O4 (594.3709)


   

2-(hydroxymethyl)-6-{5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-14'-oloxy}oxane-3,4,5-triol

2-(hydroxymethyl)-6-{5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-14'-oloxy}oxane-3,4,5-triol

C33H54O9 (594.3768)


   

2-{[6-hydroxy-6-(4-hydroxy-3-methylbutyl)-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-16-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[6-hydroxy-6-(4-hydroxy-3-methylbutyl)-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-16-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C33H54O9 (594.3768)


   

3-[(1r,2s,6s,8r)-2-[(2s,3r,4s,5e)-4-hydroxy-3,5-dimethyl-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oct-5-en-1-yl]-1,3,6,8-tetramethyl-4a,5,6,7,8,8a-hexahydro-2h-naphthalen-1-yl]-3-oxopropanal

3-[(1r,2s,6s,8r)-2-[(2s,3r,4s,5e)-4-hydroxy-3,5-dimethyl-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oct-5-en-1-yl]-1,3,6,8-tetramethyl-4a,5,6,7,8,8a-hexahydro-2h-naphthalen-1-yl]-3-oxopropanal

C33H54O9 (594.3768)


   

3-[2-(4-hydroxy-3,5-dimethyl-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oct-5-en-1-yl)-1,3,6,8-tetramethyl-4a,5,6,7,8,8a-hexahydro-2h-naphthalen-1-yl]-3-oxopropanal

3-[2-(4-hydroxy-3,5-dimethyl-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oct-5-en-1-yl)-1,3,6,8-tetramethyl-4a,5,6,7,8,8a-hexahydro-2h-naphthalen-1-yl]-3-oxopropanal

C33H54O9 (594.3768)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1's,2r,2's,4's,5r,7's,8'r,9's,12's,13's,14'r,16'r,18's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-oloxy]oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1's,2r,2's,4's,5r,7's,8'r,9's,12's,13's,14'r,16'r,18's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-oloxy]oxane-3,4,5-triol

C33H54O9 (594.3768)


   

(6r)-6-hydroxy-3-[(3e,5e,7e,9e,11e,13e,15e,17e)-18-[(4r)-4-hydroxy-2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-1-yn-1-yl]-2,4,4-trimethylcyclohex-2-en-1-one

(6r)-6-hydroxy-3-[(3e,5e,7e,9e,11e,13e,15e,17e)-18-[(4r)-4-hydroxy-2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15,17-octaen-1-yn-1-yl]-2,4,4-trimethylcyclohex-2-en-1-one

C40H50O4 (594.3709)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1's,2r,2's,4's,5s,7's,8'r,9's,12's,13's,14'r,16's,18's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-14'-oloxy]oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1's,2r,2's,4's,5s,7's,8'r,9's,12's,13's,14'r,16's,18's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-14'-oloxy]oxane-3,4,5-triol

C33H54O9 (594.3768)


   

(2r,3r,4s,5s,6r)-2-[(2r)-4-[(1r,2s,4s,6r,7s,8r,9s,12s,13r,16s)-6,16-dihydroxy-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-6-yl]-2-methylbutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-[(2r)-4-[(1r,2s,4s,6r,7s,8r,9s,12s,13r,16s)-6,16-dihydroxy-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-en-6-yl]-2-methylbutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C33H54O9 (594.3768)


   

(1r,2s,3as,3br,7s,9ar,9bs,11as)-7-hydroxy-1-[(2s,3s)-3-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h-cyclopenta[a]phenanthren-11-one

(1r,2s,3as,3br,7s,9ar,9bs,11as)-7-hydroxy-1-[(2s,3s)-3-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h-cyclopenta[a]phenanthren-11-one

C33H54O9 (594.3768)


   

(2r)-2-[(1r,2s,3as,3bs,4r,7s,9ar,9bs,11as)-4,7-dihydroxy-9a,11a-dimethyl-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methylheptan-4-one

(2r)-2-[(1r,2s,3as,3bs,4r,7s,9ar,9bs,11as)-4,7-dihydroxy-9a,11a-dimethyl-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methylheptan-4-one

C33H54O9 (594.3768)